Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

ClinicalTrials.gov ID: NCT03861936

Public ClinicalTrials.gov record NCT03861936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence: A Phase 2b, Multicenter, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Based on the results of the Phase 2 Study 191622-130 \[NCT02010775\], the current Phase 2b study is designed to further evaluate the safety and efficacy of BOTOX® for the treatment of Masseter Muscle Prominence (MMP) in adults.

Study identification

NCT ID
NCT03861936
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergan
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 16, 2019 (Actual)
Primary completion
Apr 3, 2020 (Actual)
Completion
Jul 2, 2020 (Actual)
Last update posted
Apr 28, 2021

2019 – 2020

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Total Skin & Beauty Dermatology Center, PC Birmingham Alabama 35205 —
Westside Aesthetics Los Angeles California 90025 —
Skin Care and Laser Physicians of Beverly Hills Los Angeles California 90069 —
Cosmetic Laser Dermatology San Diego California 92121 —
Baumann Cosmetic and Research Institute Miami Florida 33137 —
DeNova Research Chicago Illinois 60611 —
Etre, Cosmetic Dermatology and Laser Center New Orleans Louisiana 70130 —
Saint Louis University Dermatology St Louis Missouri 63122 —
Skin Specialists, PC Omaha Nebraska 68144 —
Nashville Centre for Laser and Facial Surgery Nashville Tennessee 37203 —
DermResearch, Inc. Austin Texas 78759 —
Bellaire Dermatology Associates Bellaire Texas 77401 —
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660 —
Advanced Clinical Research Gateway Aesthetic Institute & Laser Center Salt Lake City Utah 84101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03861936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03861936 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →